Cellnex Telecom (CLNX) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Revenues ex-pass throughs rose 7.1% year-over-year to €1,921 million, driven by organic growth, escalators, new colocations, and BTS program execution.
Adjusted EBITDA reached €1,578 million, up 5.9%, with an 82% margin; EBITDAAL grew 8.4% to €1,114 million.
Net loss attributable to the parent widened to €418 million, mainly due to a €402 million impairment in Austria and higher amortization/financial costs.
Achieved S&P investment grade status ahead of schedule and issued a new bond to repay higher-cost variable debt.
On track to meet 2024 financial outlook, with strong commercial and operational performance and robust liquidity.
Financial highlights
Organic revenues grew 7.4% year-over-year, with operating income for H1 2024 at €2,117 million, up 5.9%.
Adjusted EBITDA margin was 82%; EBITDAAL margin was 58%.
RLFCF increased to €781 million from €741 million; free cash flow reached €49 million, up by €180 million year-over-year.
Net financial debt stood at €21,078 million, with 80% at fixed rates and immediate liquidity of €3.9 billion.
CapEx for 2024: maintenance below 4% of revenues, expansion around €500 million, and build-to-suit CapEx expected at €1.3 billion.
Outlook and guidance
2024 guidance: revenues ex pass-through €3,850–3,950 million, adjusted EBITDA €3,150–3,250 million, RLFCF €1,650–1,750 million, FCF €250–350 million.
2025 guidance: revenues ex pass-through €4,100–4,200 million, adjusted EBITDA €3,400–3,500 million.
Target leverage of 5.0–6.0x Net Debt/EBITDA by 2025–2026; investment grade status to be maintained.
Minimum €3 billion dividends until 2030, payable from 2026 at the latest; up to €7 billion for buybacks and extraordinary dividends.
Guidance will be updated after completion of asset sales.
Latest events from Cellnex Telecom
- Net profit jumped to €136.5M, with €1.3B buybacks and strong revenue and margin growth.CLNX
Q4 202527 Feb 2026 - Revenue and profit growth, asset sales, and strong cash flow support strategic shift.CLNX
Q3 202415 Jan 2026 - Revenue, EBITDA, and cash flow surged; €800M buyback and dividend policy boost returns.CLNX
Q4 20247 Jan 2026 - Strong Q1 growth, portfolio streamlining, and robust buyback amid resilient sector outlook.CLNX
Q1 202518 Nov 2025 - Strong growth, margin gains, and EUR 1B shareholder returns reaffirm guidance and resilience.CLNX
Q3 20257 Nov 2025 - Solid H1 2025 growth, enhanced cash flow, and resilient long-term contracts drive outlook.CLNX
Q2 202531 Oct 2025